Your browser doesn't support javascript.
loading
Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient.
Ren, Yanyu; Li, Runrong; Feng, Hanxiao; Xie, Jieying; Gao, Lin; Chu, Shuai; Li, Yan; Meng, Fanliang; Ning, Yunshan.
Affiliation
  • Ren Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Li R; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Feng H; The First Clinical Medical School, Southern Medical University, Guangzhou, China.
  • Xie J; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Gao L; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Chu S; Department of Clinical Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Meng F; The First Clinical Medical School, Southern Medical University, Guangzhou, China.
  • Ning Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Front Immunol ; 13: 985187, 2022.
Article in En | MEDLINE | ID: mdl-36248860
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China